← Leaderboards
Margaret L Macmillan
University Of Minnesota
$3,138,767
Attributed
$3,231,167
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $906.4K · FY2012–23$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,231,167 · 2
By mechanism
R01$3,046,367 · 1
UG1$184,800 · 1
Top collaborators
- Mark Juckett1 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Jeffrey S Miller$32,066,338
- Bruce R. Blazar$144,460,093
- John E Wagner$7,593,142
- Sharon S Allen$13,896,412
- Frank Cichocki$2,728,802
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteBone Marrow TransplantationPre-ClinicalTransplantationClinical TrialsAllogenicIn VivoPositioning AttributeSafetyUniversitiesRegulatory T-LymphocyteBloodMinnesotaLymphocyteBlood ProductBlood Component RemovalAllelesActive MethodConsent FormsDisorder PreventionAdultBaseClinical ApplicationClinical Protocols
Grant awards (7)
ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML$184,800
UG1 · FY2023 · HL
Inducible Regulatory T Cells for the Prevention and Treatment of Acute GVHD$537,191
R01 · FY2016 · HL · contact PI
Inducible Regulatory T Cells for the Prevention and Treatment of Acute GVHD$529,134
R01 · FY2015 · HL · contact PI
Inducible Regulatory T Cells for the Prevention and Treatment of Acute GVHD$526,447
R01 · FY2014 · HL · contact PI
Inducible Regulatory T Cells for the Prevention and Treatment of Acute GVHD$379,998
R01 · FY2014 · HL · contact PI
Inducible Regulatory T Cells for the Prevention and Treatment of Acute GVHD$511,406
R01 · FY2013 · HL · contact PI
Inducible Regulatory T Cells for the Prevention and Treatment of Acute GVHD$562,191
R01 · FY2012 · HL · contact PI